SIAH2 protein expression is inversely correlated with the ER status and outcome to tamoxifen therapy in metastatic breast cancer patients

被引：1
|
作者：
van der Willik, K. D.
Timmermans, M. M.
Look, M. P.
Reijm, E. A.
van Deurzen, C. H. M.
den Bakker, M. A.
Westenend, P. J.
Martens, J. W. M.
Berns, E. M. J. J.
Jansen, M. P. H. M.
机构：
[1] Erasmus MC, Inst Canc, Rotterdam, Zuid Holland, Netherlands
[2] Maasstad Hosp, Rotterdam, Zuid Holland, Netherlands
[3] Pathol Lab, Dordrecht, Zuid Holland, Netherlands
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-51
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Total antioxidant status in plasma of breast cancer patients in relation to ERβ expression
    Zowczak-Drabarczyk, Miloslawa Maria
    Murawa, Dawid
    Kaczmarek, Leszek
    Polom, Karol
    Litwiniuk, Maria
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (06): : 499 - 503
  • [32] Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients
    Lekanidi, K.
    Evans, A. L.
    Shah, J.
    Jaspan, T.
    Baker, L.
    Evans, A. J.
    CLINICAL RADIOLOGY, 2013, 68 (10) : 1070 - 1073
  • [33] Breast cancer susceptibility loci as potential predictors of outcome in ER-positive postmenopausal early breast cancer patients treated with tamoxifen
    Lo, W. Y.
    Obazee, O.
    Schroth, W.
    Hoppe, R.
    Fritz, P.
    Ihring, J.
    Hamann, U.
    Schmidt, M.
    Fasching, P.
    Brauch, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S54 - S54
  • [34] Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer
    Bao-Hua Yu
    Bai-Zhou Li
    Xiao-Yan Zhou
    Da-Ren Shi
    Wen-Tao Yang
    Diagnostic Pathology, 13
  • [35] Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer
    Yu, Bao-Hua
    Li, Bai-Zhou
    Zhou, Xiao-Yan
    Shi, Da-Ren
    Yang, Wen-Tao
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [36] DYNAMIC CHANGES IN BREAST CANCER GENE EXPRESSION IN VIVO PREDICT RESPONSE TO TAMOXIFEN THERAPY IN PATIENTS WITH BREAST CANCER
    Sims, A. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 52 - 52
  • [37] High HMGN5 expression confers resistance to tamoxifen and its expression is predictive of response to tamoxifen in ER plus breast cancer patients
    Elias, D.
    Suntharalingam, L.
    Vever, H.
    Lykkesfeldt, A.
    Bak, M.
    Ditzel, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S197 - S197
  • [38] The predictive value of Her2/neu status on clinical outcome in tamoxifen-treated breast cancer patients
    Hanna, W
    Wong, JW
    Zubovits, J
    Trudeau, M
    MODERN PATHOLOGY, 2003, 16 (01) : 32A - 32A
  • [39] The predictive value of Her2/neu status on clinical outcome in tamoxifen-treated breast cancer patients
    Hanna, W
    Wong, JW
    Zubovits, JT
    Trudeau, M
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S70 - S71
  • [40] EXPRESSION OF FOXP3 IN HUMAN BREAST CANCER IS INVERSELY CORRELATED WITH DISEASE PROGRESSION AND THE METASTATIC PROCESS: AN IMMUNOHISTOCHEMICAL STUDY.
    Overbeck, D.
    Ali, S.
    Kirby, J. A.
    Lennard, T. W.
    ANNALS OF ONCOLOGY, 2009, 20 : 41 - 41
12345